Due to advances in technology and increased development of parenteral drugs, one of the fastest growing choices for drug delivery in the pharmaceutical industry is the prefilled syringe (PFS). Not ...
FRANKLIN LAKES, N.J., Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest more than $35 million ...
BD, a leading global medical technology company, is investing more than $35 million to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility. With the investment, the company ...
Sharps Technology Inc. (NASDAQ: STSS) is pushing into the copolymer prefillable syringe market thanks to a deal with Nephron Pharmaceuticals Corp., a leader in contract manufacturing of generic ...
Becton, Dickinson and Co. plans to invest more than $110 million to expand a prefilled flush syringe manufacturing facility in Nebraska. According to BD, the plan aims to better meet growing demand ...
Industry growth is strongly linked to the increasing global burden of chronic diseases such as diabetes, autoimmune disorders, and cardiovascular conditions. As treatment protocols increasingly rely ...
DUBLIN--(BUSINESS WIRE)--The "Prefilled Syringes - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Prefilled Syringes was estimated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results